Skip to main content
. Author manuscript; available in PMC: 2014 Jul 21.
Published in final edited form as: Radiology. 2012 Nov 28;266(2):502–513. doi: 10.1148/radiol.12120495

Figure 1.

Figure 1

Chart shows inclusion and exclusion criteria. DEB = doxorubicin-eluting beads, ECOG = Eastern Cooperative Oncology Group, f/u = follow-up, TACE = transcatheter arterial chemoembolization, Y-90 = yttrium 90.